When astronauts return to Earth, their altitude isn’t the only thing that drops—their blood pressure does too. This condition, known as orthostatic hypotension, occurs in up to half of those astronauts on short-term missions (two weeks or less) and in nearly all astronauts after long-term missions (four to six months). A new research report published online in The FASEB Journal (http://www.fasebj.org) solves the biological mystery of how this happens by showing that low gravity compromises the ability of arteries and veins to constrict normally, inhibiting the proper flow of blood. Prevention and treatment strategies developed for astronauts may also hold promise for elderly populations on Earth who experience orthostatic hypotension more than any other age group.
“The idea of space exploration has been tantalizing the imagination of humans since our early existence. As a scientist, I have had the opportunity to learn that there are many medical challenges associated with travel in a weightless environment, such as orthostatic hypotension, bone loss and the recently recognized visual impairment that occurs in astronauts,” said Michael D. Delp, Ph.D., a researcher involved in the work from the Department of Applied Physiology and Kinesiology, and the Center for Exercise Science at the University of Florida in Gainesville, Florida. “Although I have come to realize that it is unlikely I will ever get to fulfill my childhood dream of flying in space, I take great satisfaction with helping in the discovery of how microgravity alters the human body and how we can minimize these effects, so humans can safely explore the bounds of our universe.”
To make this discovery, Delp and colleagues examined arteries and veins from mice housed at Kennedy Space Center in Florida with blood vessels from groups of mice flown on three of the last five space shuttle missions - STS-131, STS-133 and STS-135. Mice flown on the STS-131 and STS-135 missions were tested immediately after returning to Earth, whereas mice from STS-133 were tested one, five and seven days after landing. Not only did they find that these mice experienced the equivalent of orthostatic hypotension in humans, they also discovered that it takes as many as four days in normal gravity before the condition is reversed.
“There has been considerable interest in sending humans to the moon, asteroids, and Mars,” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal, “but what we’re finding is that extended space missions have their own inherent risks above and beyond the obvious. If we ever hope to visit distant worlds for extended periods of time - or colonize them permanently - we’ve got to figure out how to mitigate the effects that low and no gravity has on the body. This report brings us an important step closer to doing just that.”
The FASEB Journal is published by the Federation of the American Societies for Experimental Biology (FASEB). It is among the most cited biology journals worldwide according to the Institute for Scientific Information and has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century. FASEB is composed of 26 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. Celebrating 100 Years of Advancing the Life Sciences in 2012, FASEB is rededicating its efforts to advance health and well-being by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Details: Bradley J. Behnke, John N. Stabley, Danielle J. McCullough, Robert T. Davis III, James M.
Dominguez II, Judy M. Muller-Delp, and Michael D. Delp. Effects of spaceflight and ground recovery on mesenteric artery and vein constrictor properties in mice. FASEB J doi:10.1096/fj.12-218503
Federation of American Societies for Experimental Biology